Glaxo scraps float plan for HIV unit

Home › Glaxo scraps float plan for HIV unit

UK pharmaceuticals firm GlaxoSmithKline decides to keep its full stake in ViiV Healthcare after robust sales of the units HIV drugs.

29.11	Could a thermal camera reveal your home's hidden heat loss?
29.11	Canada watchdog sues Google over alleged anti-competitive conduct
28.11	Haigh admits pleading guilty to 2014 criminal offence
28.11	Streambox Media launches subscription-financed TV in India
28.11	European video subscription market settles into stable phase
28.11	smartclip and Virtual Minds complete server technology integration
28.11	Telia Finland transfers cable network operation and development to Teleste
28.11	Drivers paying more than they should for fuel, says watchdog
Consumer Goods and Services »

je.st